Search Within

Dan Douer

Formats
  1. Journal Article (45)
  2. Meeting Abstract (41)
  3. Book Section (1)
Groups
  1. Department of Medicine (87)
  2. Hematologic Malignancies, Division of (87)
  3. Center for Hematologic Malignancies (60)
  4. Adult Leukemia (58)
  5. Biostatistics Service (20)
  6. Epidemiology and Biostatistics (20)

More Groups

People
  1. Martin Tallman (50)
  2. Jae Park (29)
  3. Sean Devlin (16)
  4. Peter Maslak (9)
  5. Ross Levine (9)
  6. Eytan Stein (7)

More People

Years
  1. 2021 (2)
  2. 2020 (1)
  3. 2018 (4)
  4. 2017 (3)
  5. 2016 (16)
  6. 2015 (15)

More Years

Publications
  1. Blood (38)
  2. Leukemia Research (7)
  3. Journal of Clinical Oncology (6)
  4. Acta Haematologica (4)
  5. Clinical Advances in Hematology & Oncology (4)
  6. Best Practice and Research: Clinical Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Elsevier Ltd (7)
  3. American Society of Clinical Oncology (6)
  4. Elsevier Inc. (6)
  5. Millennium Medical Publishing, Inc (4)
  6. S. Karger AG (4)

More Publishers

Results (87)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Erwinia asparaginase safety and feasibility during therapy for acute lymphoblastic leukemia in adult patients with pegaspargase hypersensitivity or severe toxicity
    Meeting Abstract

    Horvat, T. Z.; Pecoraro, J. J.; Daley, R. J.; Buie, L. W.; Douer, D.
    Blood (2015)

    Fulltext@MSK | Save
  • Herpes zoster is more frequent in patients receiving higher cumulative doses of arsenic trioxide and is mitigated by prophylactic acyclovir
    Meeting Abstract

    Glass, J. L.; Kishtagari, A.; Douer, D.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Marqibo®, vincristine sulfate liposome injection, for the treatment of advanced, relapsed or refractory Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in an adolescent young adult (AYA) population
    Meeting Abstract

    Schiller, G. J.; Damon, L. E.; Stock, W.; Coutre, S. E.; Hsu, P.; Prasad, L.; Douer, D.
    Blood (2015)

    Fulltext@MSK | Save
  • Autologous transplant, and not ATO alone, remains the preferred therapy for relapsed APL: A report from the CIBMTR, EBMT and two specialized centers
    Meeting Abstract

    Ganzel, C.; Mathews, V.; Alimoghaddam, K.; Ghavamzadeh, A.; Kuk, D.; Devlin, S.; Wang, H. L.; Weisdorf, D.; Douer, D.; Rowe, J. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • In Philadelphia-chromosome-negative acute lymphoblastic leukemia, late relapses are not uncommon, occur mostly in patients at standard risk and have a relatively favorable outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993
    Meeting Abstract

    Ganzel, C.; Victoria, W. X.; Fielding, A. K.; Rowe, J. M.; Richards, S. M.; Buck, G.; Chopra, R.; Durrant, I. J.; Marks, D.; Franklin, I. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Very poor long-term survival, also in contemporary studies, of patients with AML who relapse after achieving a first complete remission: The ECOG-ACRIN Cancer Research Group experience
    Meeting Abstract

    Ganzel, C.; Cripe, L. D.; Sun, Z. X.; Fernandez, H. F.; Cassileth, P. A.; Douer, D.; Rowe, J. M.; Paietta, E.; O'Connell, M.; Wiernik, P. H.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Acute lymphoblastic leukemia, version 2.2015
    Journal Article

    Alvarnas, J. C.; Brown, P. A.; Aoun, P.; Ballen, K. K.; Barta, S. K.; Borate, U.; Boyer, M. W.; Burke, P. W.; Cassaday, R.; Castro, J. E.; more...
    Journal of the National Comprehensive Cancer Network (2015)

    Fulltext@MSK | Save
  • Phase I trial of alpha-particle therapy with actinium-225 ((225)Ac)-lintuzumab (anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Douer, D.; Levy, M. Y.; Estey, E.; Kantarjian, H. M.; Earle, D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy
    Journal Article

    Ganzel, C.; Devlin, S.; Douer, D.; Rowe, J. M.; Stein, E. M.; Tallman, M. S.
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Clinical comprehensive genomic profiling of B-acute lymphoblastic leukemia identifies targetable kinase pathway mutations in a significant subset of cases
    Meeting Abstract

    Yao, J. J. ; Arcila, M.; Shukla, N.; Kobos, R.; Park, J.; Douer, D.; Wang, L.; Roshal, M.; Maslak, P.; Levine, R.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save